A $5 billion bet on AI-powered drug discovery led Europe’s tech funding surge this week, as investors poured more than €6 billion across 65-plus deals. The blockbuster Series C went to London-based Isomorphic Labs, backed by Sequoia and Greenoaks.
Meanwhile, the week’s action stretched far beyond a single mega-round. Paris-based Genesis AI pulled in $500 million at a $3.5 billion valuation. Bulgarian fintech Payhawk landed $280 million in a round led by Goldman Sachs.
On the mergers and acquisitions front, Swiss neurotech firm Indivi snapped up Imperial College spinout Cogitat to strengthen its AI brain-monitoring capabilities. Germany’s Green Mobility Holding moved to acquire Deutsche Dienstrad.
Investor activity also made headlines. Plural unveiled a €1 billion fund aimed at helping frontier founders build Europe’s first trillion-dollar tech company. Adesso Ventures secured €26 million in the first close of its second fund, opening its doors to external backers for the first time.
In policy news, EU-INC pressed European Commission President Ursula von der Leyen to withdraw and resubmit the EU Inc proposal. At Slush in Helsinki, tech leaders representing €100 billion in combined company value demanded political reform.
Atomico reported that European startup investment climbed to $81 billion, though capital concentration remains a persistent challenge. The report highlighted uneven distribution across regions and stages.
Several smaller rounds also caught attention. UK legal automation startup Perry AI raised $2.2 million, while Belgian compliance platform NABU secured €1.1 million. Italian healthtech Palm Health closed €1.25 million, and Brussels-based Noah raised €800,000 to help companies unlock AI potential.
The week’s numbers point to a maturing ecosystem, but regional disparities and regulatory friction continue to shape the road ahead.















